Moxibustion for pre & stage 1 hypertension: a pilot randomized controlled open trial

Korea Institute of Oriental Medicine0 个研究点目标入组 45 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1. patient age between 19 and 65 years
•2. Prehypertension or stage 1 hypertension(JNC 7)
•3. patients voluntarily participated in this experiment and signed the consent form

•1. Those who are taking prescriptions or OTC medications or herb/supplements in order to control their blood pressure
•2. Second stage hypertension patients
•3. Personal history, such as cerebrovascular diseases and cardiovascular diseases (myocardial infarction, angina pectoris, valvular heart disease, etc.)
•4. History of vicious tumor
•5. Diabetic patients taking insulin or anti-diabetic medications
•6. Those with history of kidney, liver, thyroid gland diseases
•7. Those with hemorrhagic diseases or taking anticoagulation medications(excluding aspirin)
•8. Those dependent on drugs or addicted to alcohol
•9. Those with active tuberculosis or other infectious diseases
•10. Those who have had hypersensitivity reactions following moxibustion
•11. Those who are receiving systemic steroid therapy or immunosuppressive drug therapy
•12. Those who have taken drugs that affect blood pressure in the past week or who have been taking them for a while, such as oral birth control pills, central nervous system depressants, or stimulants
•13. Pregnant mothers, lactating women and those planning for pregnancy
•14. Those who have received oriental medicine treatment related to hypertension in the past month
•15. Those who are deemed not to be suitable as judged by the person in charge of carrying out the clinical trial

发起方